Compare QGEN & FRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QGEN | FRVO |
|---|---|---|
| Founded | 1986 | N/A |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 10.0B |
| IPO Year | 1998 | 2026 |
| Metric | QGEN | FRVO |
|---|---|---|
| Price | $43.27 | $19.28 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $45.76 | N/A |
| AVG Volume (30 Days) | 3.1M | ★ 3.5M |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | ★ 7.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.18 | N/A |
| Revenue Next Year | $5.71 | N/A |
| P/E Ratio | $24.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.53 | $14.60 |
| 52 Week High | $57.82 | $41.42 |
| Indicator | QGEN | FRVO |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 41.95 |
| Support Level | $41.14 | $16.89 |
| Resistance Level | $44.22 | $27.28 |
| Average True Range (ATR) | 1.09 | 1.43 |
| MACD | -0.07 | 0.09 |
| Stochastic Oscillator | 67.64 | 36.82 |
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).